Edwards Lifesciences Corporation (BVMF:E1WL34)

Brazil · Delayed Price · Currency is BRL

101.64

-1.40 (-1.36%)

At close: Feb 6, 2026

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Transcatheter Aortic Valve Replacement Revenue	4.36B	4.11B	3.88B
Transcatheter Aortic Valve Replacement Revenue Growth	6.27%	5.83%	10.28%
Transcatheter Mitral and Tricuspid Therapies Revenue	500.00M	352.10M	197.60M
Transcatheter Mitral and Tricuspid Therapies Revenue Growth	42.00%	78.19%	70.20%
Surgical Structural Heart Revenue	1.02B	981.30M	932.60M
Surgical Structural Heart Revenue Growth	3.95%	5.22%	12.40%
Revenue (Total)	5.88B	5.44B	5.01B
Revenue (Total) Growth	8.17%	8.57%	12.23%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Revenue	3.45B	3.21B	2.95B
United States Revenue Growth	7.58%	8.76%	12.16%
Europe Revenue	1.45B	1.32B	1.18B
Europe Revenue Growth	9.83%	11.99%	13.45%
Japan Revenue	353.10M	339.80M	350.80M
Japan Revenue Growth	3.91%	-3.14%	-2.42%
Rest of World Revenue	630.10M	572.00M	531.10M
Rest of World Revenue Growth	10.16%	7.70%	21.81%
Revenue (Total)	5.88B	5.44B	5.01B
Revenue (Total) Growth	8.17%	8.57%	12.23%

Updated Sep 30, 2025. Data Source: Fiscal.ai.